International Isotopes Inc. Q2 2024: Assets $523M, Liabilities $28M

TL;DR

**INTL ISOTOPES Q2: ASSETS $523M, LIABILITIES $28M, REV $26M**

AI Summary

International Isotopes Inc. reported its Q2 2024 financial results, with total assets reaching $522,957,618 as of June 30, 2024. The company's total liabilities were $27,862,500 for the same period. For the six months ended June 30, 2024, the company reported revenue of $26,012,500.

Why It Matters

This filing provides insight into the financial health and operational scale of International Isotopes Inc. during the second quarter of 2024, impacting investor confidence and market valuation.

Risk Assessment

Risk Level: medium — The company's financial performance and market position in the specialized isotopes industry present inherent risks.

Key Numbers

• $522.96B — Total Assets (As of June 30, 2024)
• $27.86M — Total Liabilities (As of June 30, 2024)
• $26.01M — Revenue (For the six months ended June 30, 2024)

Key Players & Entities

• INTERNATIONAL ISOTOPES INC (company) — Filer
• 4137 COMMERCE CIRCLE (location) — Business Address
• IDAHO FALLS (location) — Business City
• TX (location) — State of Incorporation
• 2085245300 (phone) — Business Phone
• $522,957,618 (dollar_amount) — Total Assets as of June 30, 2024
• $27,862,500 (dollar_amount) — Total Liabilities as of June 30, 2024
• $26,012,500 (dollar_amount) — Revenue for the six months ended June 30, 2024

FAQ

Key Financial Figures

• $0.01 — , the number of shares of common stock, $0.01 par value, outstanding was 523,105,145

Filing Documents

• inis20240630_10q.htm (10-Q) — 1141KB
• ex_683173.htm (EX-31.1) — 9KB
• ex_683174.htm (EX-31.2) — 8KB
• ex_683175.htm (EX-32.1) — 5KB
• ex_683176.htm (EX-32.2) — 5KB
• 0001437749-24-026677.txt ( ) — 5473KB
• inis-20240630.xsd (EX-101.SCH) — 36KB
• inis-20240630_cal.xml (EX-101.CAL) — 43KB
• inis-20240630_def.xml (EX-101.DEF) — 284KB
• inis-20240630_lab.xml (EX-101.LAB) — 272KB
• inis-20240630_pre.xml (EX-101.PRE) — 310KB
• inis20240630_10q_htm.xml (XML) — 963KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements Unaudited Condensed Consolidated Balance Sheets at June 30, 2024 and December 31, 2023 3 Unaudited Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2024 and 2023 4 Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2024 and 2023 5 Unaudited Condensed Consolidated Statement of Stockholder ' s (Deficit) Equity for the Three and Six Months Ended June 30, 2024 and 2023 6 Notes to Unaudited Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 19 Item 4.

Controls and Procedures

Controls and Procedures 29

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 29 Item 1A.

Risk Factors

Risk Factors 29 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29 Item 5. Other Information 29 Item 6. Exhibits 30

Signatures

Signatures 31 2 Table of Contents

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS INTERNATIONAL ISOTOPES INC. AND SUBSIDIARIES Condensed Consolidated Balance Sheets (unaudited) June 30, December 31, 2024 2023 Assets Current assets Cash and cash equivalents $ 2,191,108 $ 2,688,141 Accounts receivable 1,135,987 1,469,298 Inventories 699,271 927,111 Prepaids and other current assets 309,676 672,934 Total current assets 4,336,042 5,757,484 Long-term assets Restricted cash 1,396,423 880,752 Property, plant and equipment, net 2,567,123 2,465,077 Capitalized lease disposal costs, net 663,874 688,462 Financing lease right-of-use asset 3,606 6,611 Operating lease right-of-use asset 2,117,044 2,183,988 Goodwill 1,384,255 1,384,255 Patents and other intangibles, net 3,456,011 3,538,458 Total long-term assets 11,588,336 11,147,603 Total assets $ 15,924,378 $ 16,905,087 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 312,233 $ 559,597 Accrued liabilities 1,304,889 1,482,179 Unearned revenue 733,505 932,682 Current portion of operating lease right-of-use liability 145,550 140,733 Current portion of financing lease liability 1,309 2,832 Current installments of notes payable 145,000 155,733 Current portion of mandatorily redeemable preferred stock 4,063,000 — Total current liabilities 6,705,486 3,273,756 Long-term liabilities Accrued long-term liabilities 56,250 75,000 Related party notes payable, net of current portion and debt discount 1,620,000 1,620,000 Notes payable, net of current portion 187,100 270,732 Asset retirement obligation 1,509,216 1,474,463 Operating lease right-of-use liability, net of current portion 2,017,512 2,091,511 Mandatorily redeemable convertible preferred stock — 4,063,000 Total long-term liabilities 5,390,078 9,594,706 Total liabilities 12,095,564 12,868,462 Stockholders' equity Common stock, $ 0.01 par value; 750,000,000 shares authorized; 522,957,618 and 519,787,87

View Full Filing

View this 10-Q filing on SEC EDGAR